Related Experiment Video
Updated: Sep 9, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Cardiac Troponins in Kidney Disease
Daniel Murphy1, Debasish Banerjee1
1Renal and Transplantation Unit, St George's University Hospitals NHS Foundation Trust London, UK.
Cardiac troponin levels differ in kidney disease patients, impacting diagnosis and prognosis. Understanding these changes is crucial for managing cardiovascular disease in this population.
Area of Science:
- Cardiology
- Nephrology
- Biomarker Research
Background:
- Cardiovascular disease (CVD) is a leading cause of death in individuals with kidney disease.
- Cardiac troponins are key biomarkers for diagnosing and predicting cardiac events like myocardial infarction (MI) and heart failure.
- Kidney disease alters troponin levels due to reduced clearance and increased production, complicating interpretation.
Purpose of the Study:
- To review the current evidence on cardiac troponin measurement and interpretation in patients with chronic kidney disease (CKD).
- To examine troponin levels in patients undergoing dialysis or kidney transplantation.
- To assess the relationship between troponin levels and cardiovascular outcomes in CKD populations.
Main Methods:
- Literature review of studies on cardiac troponin in kidney disease patients.
- Analysis of baseline troponin levels and changes over time.
- Examination of troponin's role in predicting cardiovascular morbidity and mortality.
- Evaluation of troponin use in acute cardiac settings for CKD patients.
Main Results:
- Elevated baseline troponin levels are common in CKD, dialysis, and post-transplant patients.
- Troponin levels in CKD patients may not correlate with acute MI as in the general population.
- Interpreting troponin requires consideration of CKD-specific factors, including renal clearance and cardiorenal syndrome.
Conclusions:
- Standard interpretation of cardiac troponins is challenging in kidney disease populations.
- Further research is needed to establish optimal protocols for troponin use in CKD patients.
- Accurate interpretation of cardiac troponins is vital for managing cardiovascular risk in individuals with kidney disease.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Nephrons
Chronic Kidney Disease I: Introduction
Acute Kidney Injury II: Pathophysiology

